These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20542770)

  • 1. Diabetes mellitus: the scary killer haunting silently.
    Capodanno D; Angiolillo DJ
    EuroIntervention; 2010 Apr; 5(8):879-81. PubMed ID: 20542770
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term mortality after PCI in patients with diabetes mellitus: results from the Swedish Coronary Angiography and Angioplasty Registry.
    Norhammar A; Lagerqvist B; Saleh N
    EuroIntervention; 2010 Apr; 5(8):891-7. PubMed ID: 20542773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Here today, gone today: time for same-day discharge after PCI.
    Blankenship JC
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):626-8. PubMed ID: 18949777
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of diabetes and acute coronary syndrome on survival in patients treated with drug-eluting stents.
    Lee MS; Jurewitz D; Zimmer R; Pessegueiro A; Bhatia R; Currier J; Yeatman L; Tobis JM
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):909-14. PubMed ID: 19016467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-eluting stenting in diabetic patients: the disease above all.
    Belardi JA
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):915-6. PubMed ID: 19016468
    [No Abstract]   [Full Text] [Related]  

  • 6. It is standard practice, but is it really best practice or clinical biocreep?
    Gilchrist IC
    Catheter Cardiovasc Interv; 2010 Oct; 76(4):525-6. PubMed ID: 20882656
    [No Abstract]   [Full Text] [Related]  

  • 7. Percutaneous coronary intervention in nonagenarians: age before beauty?
    Bhatt DL
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):531-2. PubMed ID: 18307234
    [No Abstract]   [Full Text] [Related]  

  • 8. High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting.
    Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
    Thromb Haemost; 2010 Aug; 104(2):279-86. PubMed ID: 20508896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of clopidogrel after PCI with stenting in patients on oral anticoagulants with acute coronary syndrome.
    Persson J; Lindbäck J; Hofman-Bang C; Lagerqvist B; Stenestrand U; Samnegard A
    EuroIntervention; 2011 Apr; 6(9):1046-52, 8-9. PubMed ID: 21518675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and late outcomes in patients excluded from same-day home discharge after transradial stenting and maximal antiplatelet therapy.
    Bertrand OF; Rodés-Cabau J; Larose E; Proulx G; Gleeton O; Nguyen CM; Nault I; Roy L; Poirier P; Costerousse O; De Larochellière R
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):619-25. PubMed ID: 18942124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect size of ticagrelor over clopidogrel in the Platelet Inhibition and Patient Outcomes (PLATO) trial: from statistics to clinical judgment.
    Capodanno D; Calvi V; Tamburino C
    J Cardiovasc Med (Hagerstown); 2012 Feb; 13(2):162-3. PubMed ID: 22237463
    [No Abstract]   [Full Text] [Related]  

  • 12. DES in CTO: cosmetic or clinical benefit.
    Goyal BK
    Catheter Cardiovasc Interv; 2009 May; 73(6):780. PubMed ID: 19370758
    [No Abstract]   [Full Text] [Related]  

  • 13. Contemporary outcome of cardiac catheterization in nonogenarians.
    Ohlow MA; Secknus MA; von Korn H; Wagner A; Yu J; Lauer B
    J Am Geriatr Soc; 2008 Sep; 56(9):1764-6. PubMed ID: 19166453
    [No Abstract]   [Full Text] [Related]  

  • 14. Percutaneous left main invention an evolving perspective.
    Ellis SG
    JACC Cardiovasc Interv; 2010 Jun; 3(6):642-7. PubMed ID: 20630457
    [No Abstract]   [Full Text] [Related]  

  • 15. Vitronectin concentrations predict risk in patients undergoing coronary stenting.
    Derer W; Barnathan ES; Safak E; Agarwal P; Heidecke H; Möckel M; Gross M; Oezcelik C; Dietz R; Dechend R
    Circ Cardiovasc Interv; 2009 Feb; 2(1):14-9. PubMed ID: 20031688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AUTAX (Austrian Multivessel TAXUS-Stent) registry: another useful registry on stented angioplasty for multivessel disease?
    Wijns W
    JACC Cardiovasc Interv; 2009 Aug; 2(8):728-30. PubMed ID: 19695540
    [No Abstract]   [Full Text] [Related]  

  • 17. Ectatic coronary arteries: "experienced innovation".
    Seth A
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):647-9. PubMed ID: 18949787
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and efficacy of drug-eluting stents and bare metal stents in acute coronary syndrome.
    Mahmoudi M; Delhaye C; Waksman R
    Cardiovasc Revasc Med; 2011; 12(6):385-90. PubMed ID: 21330220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.
    Novack V; Cutlip D; Kleiman N; Pencina M; Mauri L; Yen CH; Berger P; Goldberg S; Kellett M; Waksman R; Hong M; Raizner AE; Cohen DJ
    JACC Cardiovasc Interv; 2009 Aug; 2(8):767-75. PubMed ID: 19695546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stents: safe but not sufficient.
    Vogel RA
    JACC Cardiovasc Interv; 2009 Jun; 2(6):513-4. PubMed ID: 19539254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.